Maintaining homeostasis within the intestinal microbiota is imperative for assessing the health status of hosts, and dysbiosis within the intestinal microbiota is closely associated with canine intestinal diseases. In recent decades, the modulation of canine intestinal health through probiotics and prebiotics has emerged as a prominent area of investigation. Evidence indicates that probiotics and prebiotics play pivotal roles in regulating intestinal health by modulating the intestinal microbiota, fortifying the epithelial barrier, and enhancing intestinal immunity. This review consolidates literature on using probiotics and prebiotics for regulating microbiota homeostasis in canines, thereby furnishing references for prospective studies and formulating evaluation criteria.
Kennel-housed dogs may experience chronic stress affecting cognition. This study compared the effects of Lycium barbarum polysaccharides (LBP) and glycopeptide (LbGP) on cognitive function in laboratory-kenneled poodles. Eighteen dogs were assigned to CON, LBP, or LbGP groups for 42 days. Cognitive tests were performed and serum, saliva, and feces were collected for subsequent analysis. Both supplements improved cognitive performance (e.g., increased the correct rate in the cylinder test by approximately 40.0%, both p < 0.001). LBP enriched beneficial bacteria (Faecalibacterium and Bacteroides, p < 0.05), reduced pathogens (Romboutsia and Terrisporobacter, p < 0.05), and predominantly influenced the indole pathway of tryptophan metabolism. LbGP specifically decreased Escherichia-Shigella and Corynebacterium, increased fecal SCFAs, and mainly targeted the 5-HT pathway. Both treatments regulated immune function (i.e., elevated IL-6 and IL-10) and antioxidant capacity; LBP significantly increased serum superoxide dismutase (SOD) levels by 6.8% (p < 0.01) and BDNF levels by 13.5% (p < 0.05), while LbGP elevated (p < 0.01) glutathione peroxidase (GSH-Px) levels by 20.9% and reduced salivary cortisol levels by 14.2% (p < 0.01). Overall, LBP and LbGP support canine cognition through distinct microbiota-related mechanisms, likely via the microbiota–gut–brain axis, suggesting their potential as functional feed additives for cognitive health.
Objectives: The objective of the present study was to investigate the effects of Glucose oxidase (GOx) and Macleaya cordata extract (MCE) on immune response, antioxidant capacity, gut microbiota, and metabolome in cats. Methods: Twenty-four cats were randomly divided into four groups: basal diet (CON group), basal diet + 0.03% GOx (GOD group), basal diet + 0.03% MCE (MCE group), and basal diet + 0.03% GOx and 0.03% MCE (GM group). Results: Compared to the CON group, the GOD group exhibited elevated levels of total antioxidant capacity (T-AOC) and secretory immunoglobulin A (sIgA), and decreased levels of interleukin-6 (IL-6) and immunoglobulin A (IgA) (p < 0.05). MCE increased concentrations of IgA, immunoglobulin G (IgG) and sIgA, alongside a reduction in interleukin-2 (IL-2). The GM group exhibited markedly elevated concentrations of IL-2 and IgG, and decreased levels of interleukin-10 (IL-10). Moreover, 16S rRNA sequencing showed differences in the fecal microbiota among the four dietary groups. Analyses of fecal and serum metabolomics demonstrated that differential metabolites were primarily associated with cat amino acid metabolism and fatty acid metabolism. Conclusions: These findings suggest that Gox and MCE may enhance immune function, mitigate oxidative stress in cats, and increase the relative abundance of beneficial gut microbiota. Moreover, our results may provide evidence for GOx and MCE as novel nutritional additives in pet food. It should be noted that this study is limited by its sample size; while the results provide promising insights, future studies with larger-scale studies are warranted to confirm these observations.